Results 1 to 10 of about 117,022 (301)

Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. [PDF]

open access: yesPLoS ONE, 2011
BackgroundAcute rheumatic fever is considered to be a heritable condition, but the magnitude of the genetic effect is unknown. The objective of this study was to conduct a systematic review and meta-analysis of twin studies of concordance of acute ...
Mark E Engel   +4 more
doaj   +5 more sources

Diagnostic test accuracy of simplified algorithms for diagnosing acute rheumatic fever: a systematic review [PDF]

open access: yesCommunications Medicine
Background Rheumatic heart disease, the long-term sequel to acute rheumatic fever, remains a prevalent public health problem in Africa and other low to middle-income regions of the world.
Rui Providencia   +10 more
doaj   +2 more sources

Revisiting The Value of Anti-streptolysin O Titer in Children with Rheumatic Fever [PDF]

open access: yesPediatric Sciences Journal, 2022
Background: Acute rheumatic fever and rheumatic heart disease are the significant non-suppurative late sequelae of group A beta hemolytic streptococcal infection.
Mohamed S. Eid   +4 more
doaj   +1 more source

Estimated total cardiovascular risk in a rural area of Bangladesh: a household level cross-sectional survey done by local community health workers

open access: yesBMJ Open, 2021
Objective The aim of this study was to estimate 10-year cardiovascular disease (CVD) risk among Bangladeshi rural community residents, using the 2014 WHO/International Society of Hypertension (WHO/ISH) risk prediction charts.Study design Cross-sectional ...
Mohammad Mostafa Zaman   +4 more
doaj   +1 more source

Study of streptococcal antibody (anti-streptolysin O) among healthy children in Bangladesh

open access: yesSAGE Open Medicine, 2022
Objectives: The standard reference value of anti-streptolysin O (ASO) titre for diagnosing acute rheumatic fever (RF) in children is yet to be determined in Bangladesh.
Santosh Kumar Saha   +5 more
doaj   +1 more source

Treatment adherence and its determinants among the rheumatic fever/rheumatic heart disease patients during COVID 19 pandemic – A cross sectional study from Chandigarh, India

open access: yesJournal of Family Medicine and Primary Care, 2023
Background: Rheumatic heart disease/Rheumatic fever is a non – communicable disease being a major neglected health problem. Recurrent attacks of rheumatic fever can have catastrophic outcomes, therefore regular administration of antibiotics is ...
Divya Ilanchoorian   +5 more
doaj   +1 more source

How rare is isolated rheumatic tricuspid valve disease? [PDF]

open access: yes, 2020
The incidence of rheumatic fever (RF) has markedly decreased in Europe since the beginning of the 20th century due to improved living conditions, early antibiotic therapy in streptococcal pharyngitis, and changes in serotypes of circulating streptococci.
Florescu, Cristina   +4 more
core   +2 more sources

Co-designing an intervention to prevent rheumatic fever in Pacific People in South Auckland: a study protocol

open access: yesInternational Journal for Equity in Health, 2022
Background Rheumatic fever is an autoimmune condition that occurs in response to an untreated Group A Streptococcus throat or skin infection. Recurrent episodes of rheumatic fever can cause permanent damage to heart valves, heart failure and even death ...
Siobhan Tu’akoi   +7 more
doaj   +1 more source

Streptococcal Pharyngitis and Rheumatic Fever

open access: yesJournal of Pure and Applied Microbiology, 2022
Streptococcus pyogenes (Group A Streptococcus) causes a variety of diseases, from benign self-limiting infections of the skin or throat to lethal infections of soft tissue accompanied by multi-organ failure.
A. Sujhithra   +5 more
doaj   +1 more source

Evaluating efficiency and equity of prevention and control strategies for rheumatic fever and rheumatic heart disease in India: an extended cost-effectiveness analysis

open access: yesThe Lancet Global Health, 2023
Summary: Background: There is a dearth of evidence on the cost-effectiveness of a combination of population-based primary, secondary, and tertiary prevention and control strategies for rheumatic fever and rheumatic heart disease.
Jyoti Dixit, PhD   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy